Lactose (India) Ltd.

165.40 +7.85 ▲5.0%

02 March 2024, 12:50:00 PM
Volume: 1,329

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lactoseindialimited.com
Market Cap 208.22 Cr.
Enterprise Value(EV) 246.74 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 4.20 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 39.42 Trailing Twelve Months Ending 2023-12
Industry PE 41.62 Trailing Twelve Months Ending 2023-12
Book Value / Share 35.71 Trailing Twelve Months Ending 2023-12
Price to Book Value 4.63 Calculated using Price: 165.40
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.26 Cr. 12,589,000 Shares
FaceValue 10
About Lactose (India) Ltd.
Lactose (India), a Toshniwal Group company, was incorporated in 1991, under the Companies Act, 1956. Its plant in Vadodara, Gujarat was commissioned by Alfa Laval, Pune (which is a subsidary of Alfa Laval of Sweden) and was also given a ‘thumbs up' by reputed dairy experts from the Netherlands in October 1991. Subsequently Alfa Laval, reputed dairy experts from Sweden and a joint commission from the Netherlands studied the plant and its working and confidently acknowledged the plant for its quality standards as well.

Lactose (India) Ltd. Delivery

Delivered Qty
Traded Qty

Lactose (India) Ltd. Performance

1 Day
+4.98%
1 Week
+33.87%
1 Month
+28.27%
3 Month
+55.45%
6 Month
+138.26%
1 Year
+258.86%
2 Year
+211.78%
5 Year
+291.48%
10 Year
+1220.03%

Lactose (India) Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 3.25 15.69 11.95 -4.59 2.2 0.21 -7.21 6.65 3.03
Return on Capital Employed (%) 7.55 14.75 14.78 4.08 9.13 7.84 2.81 10.21 9.35
Return on Assets (%) 0.71 3.44 3.3 -1.59 0.88 0.09 -2.88 2.75 1.26

Lactose (India) Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 16 20 27 32 34 34 35 39 41 42
Non Curr. Liab. 44 37 31 38 35 38 42 36 35 30
Curr. Liab. 20 26 27 13 12 11 12 15 27 34
Minority Int.
Equity & Liab. 80 83 85 83 82 84 88 90 102 106
Non Curr. Assets 67 66 68 66 64 64 69 67 64 62
Curr. Assets 13 17 17 17 18 20 20 23 38 44
Misc. Exp. not W/O
Total Assets 80 83 85 83 82 84 88 90 102 106

Lactose (India) Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 24 34 36 31 41 40 35 46 66 110
Other Income 0 1 1 1 0 0 0 1 1 1
Total Income 24 36 37 32 41 40 35 47 67 111
Total Expenditure -19 -24 -24 -25 -31 -31 -29 -34 -54 -94
PBIDT 5 12 12 6 10 10 7 13 12 18
Interest -3 -4 -4 -5 -5 -6 -5 -5 -6 -6
Depreciation -2 -3 -3 -4 -4 -4 -4 -5 -5 -5
Taxation 0 -1 -2 1 0 0 1 -1 0 -2
Exceptional Items
PAT 1 3 3 -1 1 0 -2 2 1 5
Adjusted EPS 1 3 3 -1 1 0 -2 2 1 4

Lactose (India) Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 7 13 1 8 0 5 7 2 8 8
Cash Fr. Inv. -21 -23 3 -5 -2 -2 -3 -6 -1 -1
Cash Fr. Finan. 13 10 -5 -3 4 -5 -4 5 -8 -8
Net Change -1 -1 0 0 3 -2 1 1 0 -1
Cash & Cash Eqvt 1 0 0 0 3 1 2 2 2 1

Lactose (India) Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 52.50 53.79 53.79 53.79 53.79 53.79 53.79 53.77 53.66
Public 47.50 46.21 46.21 46.21 46.21 46.21 46.21 46.23 46.34
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 41.21 39.13 0.52 0.52 48.34 48.34 0.00 26.01 26.06

Lactose (India) Ltd. Announcements

Sat, 02 Mar 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations 2015 we hereby submit the intimation towards the issue of duplicate of share certificate.
Sat, 02 Mar 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations 2015 we hereby submit the intimation towards the issue of duplicate share certificate.
Sat, 02 Mar 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations 2015 we hereby submit the intimation towards the loss of share certificate.

Lactose (India) Ltd. Technical Scans

Sat, 02 Mar 2024
Close Crossing 52 Week High Close Crossing 52 Week High
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
Closing Above Previous High For 3 Days Closing Above Previous High For 3 Days
Making Higher Highs for 3 days Making Higher Highs for 3 days

Lactose (India) Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 372,148.85 1,552.90 -0.4%
Cipla Ltd. 119,740.36 1,483.15 +0.8%
Dr. Reddy's Laboratories Ltd. 104,108.09 6,241.00 +0.7%
Zydus Lifesciences Ltd. 93,396.08 922.70 -0.3%
Divi's Laboratories Ltd. 93,071.96 3,505.30 +0.8%
Torrent Pharmaceuticals Ltd. 91,273.66 2,695.30 +1.1%
Apollo Hospitals Enterprise Ltd. 88,246.40 6,132.40 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.79 1,552.90 -0.4%
Cipla Ltd. Consolidated 2023-12 32.29 1,483.15 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.91 6,241.00 +0.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.41 922.70 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-12 67.30 3,505.30 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 61.09 2,695.30 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 111.80 6,132.40 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.96 1,552.90 -0.4%
Cipla Ltd. Consolidated 2023-12 4.62 1,483.15 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.87 6,241.00 +0.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.80 922.70 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-12 7.14 3,505.30 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.77 2,695.30 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.07 6,132.40 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,552.90 -0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,483.15 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,241.00 +0.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 922.70 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,505.30 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,695.30 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,132.40 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,552.90 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,483.15 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,241.00 +0.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.70 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,505.30 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,695.30 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,132.40 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,552.90 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,483.15 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,241.00 +0.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.70 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,505.30 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,695.30 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,132.40 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,552.90 -0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,483.15 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,241.00 +0.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 922.70 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,505.30 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,695.30 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,132.40 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,552.90 -0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,483.15 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,241.00 +0.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 922.70 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,505.30 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,695.30 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,132.40 +0.8%

Lactose (India) Ltd. FAQ's

What is Lactose India share price?

Can I buy Lactose India shares now?

What is the Market Cap of Lactose India?

What are the key metrics to analyse Lactose India?

What is the 52 Week High and Low of Lactose India?

What is the trend of Lactose India share price?